Olema Pharmaceuticals, Inc.

OLMA Healthcare Biotechnology

In the quarter to June 2026, EPS fell 19.6%, free cash flow fell 54.3% and total debt was flat, each against the same quarter a year earlier.

6.58 0.29 −4.22%
Market cap
$601.1M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash and Short Term Investments
505.44 434.09 261.81 204.42 287.25 338.55 0.07 3.15
Total current assets
515.45 438.47 266.51 208.90 290.69 342.14 0.10 3.24
Property, Plant, Equpment (Net)
— — — — 1.47 0.08 0.03 0.03
Long-term assets (Other)
16.83 11.19 8.14 4.25 0.54 0.51 0.00 0.00
Total non-current assets
17.98 12.51 10.43 6.75 5.26 0.59 0.03 0.03
Total Assets
533.43 450.98 276.95 215.65 295.95 342.72 0.13 3.27
Accounts Payable
9.25 4.46 2.70 0.37 0.02 0.72 0.94 0.12
Other current liabilities
41.43 36.13 17.94 15.16 8.07 3.87 0.44 0.09
Total current liabilities
51.80 41.76 21.62 16.55 9.02 4.59 1.38 0.20
Long Term Debt (Total)
3.00 — — 1.55 2.36 — — —
Total non-current liabilities
3.07 0.26 1.43 1.55 2.36 — — —
Total liabilities
54.87 42.02 23.05 18.10 11.38 4.59 1.38 0.20
Additional Paid In Capital
1,075.49 843.92 559.18 408.33 388.90 371.23 0.17 0.17
Preferred Stock (Total)
— — — — — — 9.35 9.35
Common Stock (Net)
0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
(597.56) (435.11) (305.63) (208.98) (104.19) (33.09) (10.76) (6.45)
Common Equity (Total)
478.56 408.96 253.90 197.55 284.57 338.14 (10.59) (6.28)
Shareholders Equity (Total)
478.56 408.96 253.90 197.55 284.57 338.14 (1.25) 3.07
Shareholders Equity and Liabilities (Total)
533.43 450.98 276.95 215.65 295.95 342.72 0.13 3.27
Shares (Common)
81.38 74.31 54.99 40.29 39.80 39.31 2.59 2.59
Shares (Preferred)
— — — — — 0.00 4.63 4.63
Shareholders Equity (Tangible)
478.56 408.96 253.90 197.55 284.57 338.14 (1.25) 3.07
Net Debt
(502.44) (434.09) (261.81) (202.87) (284.89) (338.55) (0.07) (3.15)
Total Debt
3.00 — — 1.55 2.36 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates